These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 11550783)
1. Yohimbine in erectile dysfunction: would an orphan drug ever be properly assessed? Morales A World J Urol; 2001 Aug; 19(4):251-5. PubMed ID: 11550783 [TBL] [Abstract][Full Text] [Related]
2. Yohimbine in erectile dysfunction: the facts. Morales A Int J Impot Res; 2000 Mar; 12 Suppl 1():S70-74. PubMed ID: 10845767 [TBL] [Abstract][Full Text] [Related]
3. Yohimbine in erectile dysfunction: the facts. Morales A Int J Impot Res; 2000 Mar; 12(S1):S70-S74. PubMed ID: 10849568 [TBL] [Abstract][Full Text] [Related]
4. Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. Ernst E; Pittler MH J Urol; 1998 Feb; 159(2):433-6. PubMed ID: 9649257 [TBL] [Abstract][Full Text] [Related]
5. Yohimbine treatment of organic erectile dysfunction in a dose-escalation trial. Guay AT; Spark RF; Jacobson J; Murray FT; Geisser ME Int J Impot Res; 2002 Feb; 14(1):25-31. PubMed ID: 11896474 [TBL] [Abstract][Full Text] [Related]
7. Yohimbine can be the new promising therapy for erectile dysfunction in type 2 diabetics. Tanweer MS; Fatima A; Rahimnajjad MK J Pak Med Assoc; 2010 Nov; 60(11):980. PubMed ID: 21375213 [No Abstract] [Full Text] [Related]
8. [Yohimbine in the treatment of erectile dysfunction]. Pushkar' DIu; Segal AS; Bagaev AG; Nosovitskiĭ PB Urologiia; 2002; (6):34-7. PubMed ID: 12577576 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of high dose yohimbine hydrochloride on organic erectile dysfunction. Telöken C; Rhoden EL; Sogari P; Dambros M; Souto CA J Urol; 1998 Jan; 159(1):122-4. PubMed ID: 9400452 [TBL] [Abstract][Full Text] [Related]
10. Double-blind, placebo-controlled safety and efficacy trial with yohimbine hydrochloride in the treatment of nonorganic erectile dysfunction. Vogt HJ; Brandl P; Kockott G; Schmitz JR; Wiegand MH; Schadrack J; Gierend M Int J Impot Res; 1997 Sep; 9(3):155-61. PubMed ID: 9315493 [TBL] [Abstract][Full Text] [Related]
11. [Individualising the evidence--single case randomized trial]. Haefeli WE Ther Umsch; 2006 Dec; 63(12):777-81. PubMed ID: 17133300 [TBL] [Abstract][Full Text] [Related]
12. Oral medications in the management of erectile dysfunction. Lawless C; Cree J J Am Board Fam Pract; 1998; 11(4):307-14. PubMed ID: 9719353 [No Abstract] [Full Text] [Related]
13. Efficacy and safety of a novel combination of L-arginine glutamate and yohimbine hydrochloride: a new oral therapy for erectile dysfunction. Lebret T; Hervé JM; Gorny P; Worcel M; Botto H Eur Urol; 2002 Jun; 41(6):608-13; discussion 613. PubMed ID: 12074777 [TBL] [Abstract][Full Text] [Related]
16. An oral yohimbine/L-arginine combination (NMI 861) for the treatment of male erectile dysfunction: a pharmacokinetic, pharmacodynamic and interaction study with intravenous nitroglycerine in healthy male subjects. Kernohan AF; McIntyre M; Hughes DM; Tam SW; Worcel M; Reid JL Br J Clin Pharmacol; 2005 Jan; 59(1):85-93. PubMed ID: 15606445 [TBL] [Abstract][Full Text] [Related]
17. [Treatment per os of disorders of erection]. Giuliano F Prog Urol; 1997 Feb; 7(1):108-9. PubMed ID: 9116726 [No Abstract] [Full Text] [Related]
18. Erectile dysfunction and scleroderma. Johnson SR; Dewar C J Rheumatol; 2004 Oct; 31(10):2091; author reply 2091-2. PubMed ID: 15487075 [No Abstract] [Full Text] [Related]
19. Combination therapy for erectile dysfunction: a randomized, double blind, unblinded active-controlled, cross-over study of the pharmacodynamics and safety of combined oral formulations of apomorphine hydrochloride, phentolamine mesylate and papaverine hydrochloride in men with moderate to severe erectile dysfunction. Lammers PI; Rubio-Aurioles E; Castell R; Castaneda J; Ponce de Leon R; Hurley D; Lipezker M; Loehr LA; Lowrey F Int J Impot Res; 2002 Feb; 14(1):54-9; discussion 60. PubMed ID: 11896479 [TBL] [Abstract][Full Text] [Related]
20. Design and evaluation of nitrosylated alpha-adrenergic receptor antagonists as potential agents for the treatment of impotence. de Tejada IS; Garvey DS; Schroeder JD; Shelekhin T; Letts LG; Fernández A; Cuevas B; Gabancho S; Martínez V; Angulo J; Trocha M; Marek P; Cuevas P; Tam SW J Pharmacol Exp Ther; 1999 Jul; 290(1):121-8. PubMed ID: 10381767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]